First Affiliated Hospital Of Guangxi Medical University
Clinical trials sponsored by First Affiliated Hospital Of Guangxi Medical University, explained in plain language.
-
Ovarian puncture may boost egg count in women with low reserve
Disease control Not yet recruitingThis study looks at whether making small punctures in the ovary during egg retrieval can help women with low ovarian reserve (DOR) produce more eggs in a later cycle. About 214 women undergoing IVF will be randomly assigned to get the puncture procedure or standard care. The main…
Phase: NA • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a common stroke drug help patients over 80?
Disease control Not yet recruitingThis study is testing whether the clot-busting drug tenecteplase is safe and effective for people aged 80 and older who have had a stroke. Researchers will track 392 patients to see how well they recover and if there are any serious side effects. The goal is to find out if this t…
Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for Wake-Up stroke patients: drug may boost recovery
Disease control Not yet recruitingThis study tests a medicine called tenecteplase for people who have a stroke but don't know exactly when it started, like waking up with symptoms. About 352 adults will get either tenecteplase or standard care after a simple CT scan. The goal is to see if the drug helps them reco…
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New combo therapy aims to tackle tough sarcomas
Disease control Not yet recruitingThis phase 2 trial is testing a new treatment for soft tissue sarcoma that combines a special type of radiation with immunotherapy and immune-boosting drugs. The goal is to see if this combination can shrink tumors and improve outcomes for people with advanced or recurrent sarcom…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Experimental CAR-T therapy targets tough childhood leukemia
Disease control Not yet recruitingThis early-phase study tests a new treatment called CLL-1 CAR-T for children aged 3 to 18 with acute myeloid leukemia that has come back or not responded to standard therapy. Ten participants will receive an infusion of their own modified immune cells after chemotherapy. The main…
Phase: EARLY_PHASE1 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can a stem cell spray stop radiation mouth pain?
Prevention Not yet recruitingThis study tests an oral spray made from stem cell exosomes to prevent severe mouth sores in head and neck cancer patients undergoing radiation. 200 participants will use the spray three times daily, starting a week before radiation and continuing for two weeks after. The goal is…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Prevention
Last updated Jun 27, 2026 08:07 UTC
-
AI doctor takes on urology: can a chatbot outperform human specialists?
Knowledge-focused Not yet recruitingThis study will test a special AI program called UroMed AI Doctor, designed to help with urology care. Researchers will compare AI-assisted care to traditional care from a specialist for patients with kidney stones, enlarged prostate, or bladder cancer. The goal is to see if the …
Phase: NA • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC